CASTLE PARTNERSHIP — All Prescriptions & Medications — Page 11
Practice Code: D82011 | NORWICH, NR3 1SE
Showing results 501-550 of 697
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Colistimethate sodium | 30 | 1,740 | £5.2K | +165.3% ▲ |
| Trospium chloride | 30 | 1,070 | £586 | -41.2% ▼ |
| 30 | 570 | £628 | +210.5% ▲ | |
| Naratriptan hydrochloride | 29 | 324 | £62 | +10.9% ▲ |
| Lisinopril with diuretic | 28 | 1,176 | £380 | +36.5% ▲ |
| Ciprofibrate | 28 | 784 | £2.0K | +109.7% ▲ |
| Almotriptan | 28 | 207 | £452 | +125.9% ▲ |
| Rotigotine | 28 | 889 | £4.2K | +3.8% ▲ |
| Valaciclovir | 28 | 954 | £1.5K | +99.3% ▲ |
| Ketorolac trometamol | 28 | 140 | £115 | +201.8% ▲ |
| 28 | 167 | £467 | -14.7% ▼ | |
| 28 | 754 | £479 | -16.1% ▼ | |
| Zinc oxide | 27 | 914 | £126 | +30.5% ▲ |
| Reboxetine | 27 | 2,008 | £603 | +75.3% ▲ |
| Dexamethasone | 27 | 991 | £170 | -13.4% ▼ |
| Magnesium glycerophosphate | 27 | 1,911 | £774 | +96.5% ▲ |
| Brimonidine tartrate | 27 | 220 | £105 | -32.4% ▼ |
| 27 | 3,375 | £43 | +7.4% ▲ | |
| 27 | 550 | £129 | +20.9% ▲ | |
| Diltiazem hydrochloride | 26 | 780 | £328 | +461.3% ▲ |
| Bempedoic acid/Ezetimibe | 26 | 1,037 | £2.0K | -57.4% ▼ |
| Mometasone/glycopyrronium/indacaterol | 26 | 780 | £1.1K | +71.5% ▲ |
| Glucagon | 26 | 28 | £323 | +70.9% ▲ |
| RtS 1.5 - 1.6 kcal/ml milkshake with fibre (0913011) | 26 | 243.2K | £3.5K | +95.6% ▲ |
| Betamethasone sodium phosphate | 26 | 310 | £69 | +0.4% vs avg |
| Acetazolamide | 26 | 2,814 | £107 | +20.0% ▲ |
| Linaclotide | 25 | 784 | £999 | +36.8% ▲ |
| Potassium chloride | 25 | 1,366 | £140 | +33.7% ▲ |
| Budesonide | 25 | 33 | £317 | +60.7% ▲ |
| Fludroxycortide | 25 | 40 | £926 | +137.1% ▲ |
| 25 | 855 | £3.1K | +115.3% ▲ | |
| Formoterol fumarate | 24 | 43 | £1.1K | +67.4% ▲ |
| Lofepramine hydrochloride | 24 | 1,624 | £699 | -19.8% ▼ |
| Ciprofloxacin | 24 | 120 | £107 | +202.0% ▲ |
| Crotamiton | 24 | 2,320 | £136 | +44.3% ▲ |
| 24 | 4,000 | £570 | -38.4% ▼ | |
| 24 | 1,800 | £4.6K | +128.4% ▲ | |
| Nizatidine | 23 | 1,716 | £1.2K | -33.1% ▼ |
| Soluble insulin (Neutral insulin) | 23 | 110 | £1.1K | +138.7% ▲ |
| Biphasic insulin lispro | 23 | 115 | £702 | -46.4% ▼ |
| Combined ethinylestradiol 35mcg | 23 | 2,016 | £137 | +84.6% ▲ |
| Tube feed 1.5 kcal/ml peptide based (0914041) | 23 | 720.0K | £15.5K | +116.1% ▲ |
| Hydrocortisone acetate | 23 | 240 | £759 | +248.0% ▲ |
| 23 | 566 | £1.3K | -47.7% ▼ | |
| 23 | 78 | £1.5K | +66.5% ▲ | |
| 23 | 570 | £391 | +12.9% ▲ | |
| Metolazone | 22 | 176 | £1.3K | +211.8% ▲ |
| Aclidinium bromide/formoterol | 22 | 22 | £680 | -37.4% ▼ |
| Aspirin | 22 | 837 | £174 | +123.9% ▲ |
| Analgesics with anti-emetics | 22 | 1,116 | £408 | +55.5% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.